People: Corcept Therapeutics Inc (CORT.OQ)
19 Jul 2019
Dr. Joseph K. Belanoff, M.D., is President, Chief Executive Officer, Director of Corcept Therapeutics Incorporated. Dr. Belanoff is a co-founder of our company and has served as a member of our Board and our Chief Executive Officer since Corcept’s inception in 1999, and as our President since 2014. Dr. Belanoff is an Adjunct Professor of Psychiatry at Stanford University (School of Medicine), where he has held positions in the Department of Psychiatry and Behavioral Sciences since 1992. Dr. Belanoff received his B.A. from Amherst College and his M.D. from Columbia University’s College of Physicians & Surgeons. Dr. Belanoff brings to our Board a deep knowledge of our financial activities, commercial operations and our research and development programs. He also has valuable expertise in business administration, drug discovery, clinical medicine and psychopharmacology.
|Total Annual Compensation, USD||1,157,540|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||5,157,080|
|Fiscal Year Total, USD||6,314,620|